title: Multigene assays to improve assessment of recurrence risk and benefit from chemotherapy in early-stage colon cancer: has the time finally arrived, or are we still stage locked?
authors.forename: Josep
authors.initials: J
authors.lastname: Tabernero
authors.forename: José
authors.initials: J
authors.lastname: Baselga
mesh_terms: D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D020869:Gene Expression Profiling; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D012008:Recurrence